Document 444746
"-, &ก
! 18 - 24 LQRก 2557
%-!-'-,-+ &.
3 ก 2557
"<474""&"#6
>I"( กก
292 กL'@%2I 6 " I' <3%M ก9("& @%NกL!
"<474
""&"#6
>7 I'
"<474O2
2 %P' (262กก%
("! I' <""
6"2Q@%(%ก
2@! !ก%
("!A<7
9(6 < Pก!ก7 '"ก
2
%Q&'"6Kก% I'
26 " ก(N7กก(
ก3(
ก"/"& ก "0& %
")ก
K Global Healthcare Equity Fund : K-GHEALTH
ก
ก !
"#
ก ก..%.
ก%&' ก ((Feeder fund)
ก ก
2. ก"ก3 #ก
(
=6ก #ก
( (4)
"#
ก ก..%.
ก!"#ก!ก % 3!4
ก&&" %'
ก
3
ก ') *ก ก+ ก,
3 ก 4 6
7%&8 9(!
%3 ก
' 100 ก#3"'"<ก#3"=
<กก#3"'"<ก#3"=!
2'' 2
>4' &?@
& J!*ก "/K, %' ก
#กA<7
!"!
B
IPO: &G(A<7!
8 =.6. 2557
&' *' &ก 3 ก 3.75% 6
K""=
) L-+ %'& "-!,ก
' "(
ก L-!ก
S ก!ก JPMorgan Funds Z Global Healthcare Fund, Class A
(acc) - USD !
%"9( O!2&82
>43ก' 80 6
K"ก
Uก& "-! ก ก"!
S !"BกK&ก% ก &G( 6 9ก2 iKI6K '!"
>>A<7 <
&mก
6 "(
%Iก &3ก' 75 6 !%&' ก ,ก' "R
S ก JPMorgan Funds Z Global Healthcare Fund, Class A (acc) '!%"
2L
&'ก2=ก(I"B
9ก3ก' 67 6
K"ก (3
"(I'ก 2 "()
ก
ก!"
>>A<7 <&mก
6 " (Hedging) < < &'"=Bก2ก (Efficient Portfolio Management)
กV*ก % ก
S ก &G( 6 9ก2 iKI6K !@%2I!ก 6ก
2ก JPMorgan Funds
Z Global Healthcare Fund (ก
ก) ก"(
S ก JPMorgan Funds Z Global Healthcare Fund !ก%"ก(I"B
9ก AN
%ก > %29%" <"@%2I(!''
(!-'ก',ก
S @ก(# ก JPMorgan Funds Z Global Healthcare Fund
S B'%(
ก
K&' ก
ก
S &?
LnกI'ก <&' ก
ก
S ก &I&
%Iก & %%&' ! (Benchmark) ,ก
(
4 MSCI World Healthcare Index (Total Return Net) (%
47
(ก
ก) &
2(%
ก&mก
6 "
%Iก & < 2ก
26"ก 2 6#@%2I
%"
("ก#"
>>&mก
6 "(
%Iก &&'' 75 I'&
2(
%Iก & < 2ก
26"ก 2 6#@%2I %"
("33(#
"
>>&mก
6 "(
%Iก &&'' 25
26 ก 2557
( &I&3()
3ก#(
ก"% ก")*
ก7 '"ก
2@%ก@%2Iกก!%"I2L
&'ก2=ก(I"B I'
26 "กก3("%
7I%'(
2 6-8 9(6(
@%2I(!''
(& "-!!-+ &.
S 6 "ก6@
@6
ก
K (Market Risk)
S 6 " ก(กก &I&ก < 92ก ก6
<"B' Lnก
&' ก
ก (Country and Political Risk)
S 6 "6 &I&
<ก@ก(# I'n'ก 2L
@ก%" (Business Risk)
S 6 "กกq2
6
2%M (Regulatory Risk) 4 %ก626กIก & %
%&' S 6 "ก#ก
(ก# ก
2&' (Repatriation Risk)
S 6 " ก(กก3"Q#
ก
K
7M 3(!6 '"I'B!
'' "6 (Liquidity Risk)
S 6 "กก
24#'6< (Settlement Risk)
S 6 "กก@(
(4#'76"
>>"& %%&' (Default Risk)
S ก'
6 "ก
%Iก & (Exchange Rate Risk) <กก33(
&mก
6 "ก
%Iก &
7#
&+ "!-+ &.
S ก
ก!"
>>A<7 <(6 " (Hedging) < < &'"=Bก2ก (Efficient Portfolio Management) (
7 ก
กN6 "
กกก< 77 ก
ก#ก&mก
6 "(
%Iก & <
!"
>>A<7 <! currency exposure !ก 6ก
2(
447
(ก
S ก
ก!
K"!"ก <!(ก <ก"ก (K"
n ก (USD)
I'#ก&mก
6 "(
%Iก & <!"
>>A<7 <!
currency exposure !ก 6ก
2(
447
(ก
S ก
ก' !ก%"ก!(%"กN (
7 ก
ก6
@
@กกกกก'ก!ก%"ก
S ก33(&mก
6 "(
%Iก &
7# !"BกK&ก% ก'
!"
>>A<7 <&mก
6 "(
%Iก &3ก' 75 6 !%&' 3กP( !ก"BกK3&ก% ก&mก
--',")L-!ก
&+ "!-+ &. (')
(1) ,L-!ก%ก-- 10 ก !!
%กL
%- %ก
%NAV
B"
4ก
8.00%
Johnson & Johnson
B"
4ก
5.50%
Roche
B"
4
ก
5.40%
Novartis
B"
4ก
4.60%
Bristol-Myers Squibb
6994B
4.00%
Biogen
6994B
3.40%
Celgene
B"
4
ก
3.30%
Sanofi
B"
4ก
3.20%
Bayer
2ก(ก(I"B
2.90%
UnitedHealth
Gilead Sciences
6994B
2.80%
(2) --'ก ก %- %ก
%- %ก
ก%ก
!!
B"
4ก
52.00%
59.40%
6994B
23.90%
14.60%
2ก(ก(I"B
10.90%
11.90%
699กIK
9.60%
14.10%
"(
3.60%
0.00%
100.00%
100.00%
(3) ก + " ,ก JPMorgan Funds c Global Healthcare Fund,
Class A (acc) - USD
ก%ก
!
6 "%(@
(กก ก%
4 ก6 2%(K"
n ก
6% <"@ก'2 42%กก ก&mก
6 "
(
%Iก &ก' 75 6 !%&' <ก6 2
%(K"
n กIP6N7% <"@ก'2 42%กก
ก&mก
6 "(
%Iก &3ก' 90 6 !%
&' <กก &I&92ก AN6('"@ก'2%6 !''
ก&mก
6 "%(@
(กก &|%
S <กก!%&' ANกP6< ก JPMorgan Funds Z Global Healthcare Fund
(ก
ก) 2L
(ก'"6#"
A<7ก
ก3&%
I
26#"
A<7!
&' "69&K 9(!4"ก (K"
n ก (USD) AN%
I(
ก'"6#"
A<7
(
ก3&
&' ก A 2Kก%3& กN6 "ก&' (
ก
ก%ก!B' ก(ก%กK3&ก% < ก(ก &I&( Lnก ก <
<"
6 #!ก3"Q# ก
2 !&' AN"@!@3(
24#' 66<4ก'' ก#(3!
"<474
S <กก !ก
ก ก ( ANก
ก92 !
%"2L
&'ก2=ก(I"B #!@6 "ก6
@
@กกก<92ก'ก!%"!ก%"ก3(
@N(<3(
2 6<%#ก Iก3(
S ก""='3 "กก
2< <&'94K&' "
n ก <"
n ก<@Qn!"
n ก <266AN9(&ก%Q
!"
n กQNก
K"266(
กI'2L
<"AN
(!N7I'
(# กก!"
n ก
1 "
3 "
1 i
3 i
5 i
10 i
1.98%
0.43%
5.16%
3.46%
25.77%
24.85%
157.62%
98.17%
184.72%
121.03%
208.36%
155.51%
% : ก Factsheet ก
ก 30 ก
2557
77 @"Q( &|&?2
3( website www.jpmorganassetmanagement.lu
&' V"!
j &' V"!!"!ก"กo กก (% 'i, NAV)
&' *' %
'"ก 3.75%
3 ก
3.00%
ก
(ก 1
1
3
ก
0.25%
@(I@&'94K
1
3 ก
0.30%
' 2
6!4<M
3 ก
1.00%
1
&?2
&?2
&?2
1.00%
0.03%
0.075%
&|
%
3BL6 j &' V"!!"!ก"กo กJ%' (% ,&' K, )
6= ก
3 ก
3.00%
4 IPO
1.00%
IPO
1.50%
6= ก
2A<76<
3 ก
3.00%
&?2
ก 6= ก"
2 &
ก
26= ก
2A<76<ก%
<6= กก&
II%
%!("ก
*6= @ก'2%@%2I@'3(
2 (
7 @6ก ก กP2
6= (
กกก*
-J ,"L"
S 2L
ก
K
(กก ก"ก3 #ก
(
: 400/22 6=6ก"ก3 4
7 6 Q9= I" "! %>3
ก 10400
9
K 0-2673-3888 9" 0-2673-3988
Website : www.kasikornasset.com Email : ka.customer@kasikornasset.com
S @"Q"2Q % I'
2
"<474 I'96กI'@ก
3(
2L
(กI'@"
2"กI'
2A<76<
,ก K/, %'
j + "
&ก j ก K%' :
#กA<7
6
7%#กA<76
7Iก
6
7%#กA<76
7Q
(3&
j ก , &%' :
5,000 2
ก
#ก9(A<73(B! 15.30 .
5,000 2
5,000 2
#ก6<
ก
#ก9(3(B! 15.30 .
6
7%#ก6<
5,000 2
(6 <
7%#
5,000 2
'' ก
2 66<
4 #กQ
(ก
#ก (T+4 15.00 .)
S @"Q%"26
K"
3( Website: www.kasikornasset.com
2L
(ก 9. 0-2673-3888 I'2. =6ก"ก3ก"<9. 0-2888-8888
,s
ก%ก:
JPMorgan Funds Z Global Healthcare Fund, Class A (acc)
")ก: ก%"I
-ก"
USD
!"!: 2 %6 2552
ก :
JPMorgan Asset Management (Europe) S.à r.l.
(
4 MSCI World Healthcare Index (Total Return Net)
!:
&' V"!ก , %':
3 ก' 5.00 6
3 ก' 0.50 6
&' V"!ก K&%':
&' V"!ก ก !qก ก : 3 ก' 1.50 %&8 NAV
&' *' *ก + " ก % : 3 ก' 0.40 %&8 NAV
rก &' V"!&' *' %!"!ก"กo กก*" .!
!' : &?2
' 1.90 %&8 NAV ( (<กกq6 2557)
Bloomberg Ticker: JPHLUAA LX
J-&ก ก
ก
%Q&'"6K'"@%2Iกก!%"I2L
&'ก2
=ก(I"B
9ก
กVก ก
ก'!%"2L
&'ก2=ก(I"B3ก' 67 6
K"ก (3 "(I'ก 2 "() 9(@ก
ก
K(
ก
%
7!&' !(กP3( QN%( ก(! I'ก
ก3AN%"7 "( I'
ก 2 "( "3!ก3(
,s (')
& "-!,ก%ก
1) 6 "กก#"
>>A<7 (Futures) I'"
>>&4
(Options)
2) 6 "กก!%"
=K (Derivative Risks)
2.1) 6 "กก(!ก!%"
=K (Leverage Risk)
2.2) 6 "กก'
2กA<7%"
=K
2.3) 6 "("B6
ก
Kก (Liquidity Risk)
3) 6 "กก!2L
( Pก
4) 6 "กก!%( ก(!I'&' (
กราฟแสดงผลตอบแทนยอนหลัง 5 ป ของกองทุน JPMorgan Funds – Global Healthcare Fund (กองทุนหลัก)
"!"!ก! MSCI World Healthcare Index (Total Return Net) (!)
(1) : Morningstar %
7I%
28 %6 2552 QN 27 %6 2557
(2) @%2I!(%ก3( &|"<
QN@%2I!6%
(!-'ก'ก * - %',*ก'- %ก-,) L
ก
1. (ก
1.1 6%กก2ก("BI'@%B
KกIKก %29%N7 <ก&'4ก@" ( 60 &8N73&) 9ก 7!&' I
I'&' ก(!I9"N7
1.2 3(I'ก#32L
(' 2!ก"B &|N!ก%"ก@ก(# 9(( ( I'
"Q %29%3&3(ก 9( O'!&' ก(!( %29%N7 P3(4
(
1.3 6!4("B <6( &|"
("%6 Lnก9ก I9 %29%N7ก O&8'ก 5% 3&QN&8 2560
1.4 ก&&'22"="B6
n!&' ObamaCare &' "
n ก "
2"!&'44 QN&'ก
"B3(N7
#!#@"Q QN'22
กL2 N7
1.5 %"ก!ก 6994B (Biotechnology)I' B"
4ก (Phamacuetical) ก%
( P(
%ก"%K!M
<%2"%&"6K"BI'กIIK
2. (
2.1 B' "@"=" < Patent Cliff AN ก(กก"=2
%%
4< "( #!6I%%#ก' I
I''"@2%@&'ก2ก@&'ก2=ก&?2
ก#
Q<"=2
%
2.2 '(
26&?2
!ก"B6" < 2ก
2ก<M #!
ก
3&!ก%"ก<M6%#ก
S ก!3!4กก 733(B!%666"Q2
66 ก N6 "กกAN@ 33(
2 6< %P#
S !"QกK3&ก% @Q<3"Q6< <3(
24#'66<4ก'' ก#(3!
"<474
S @ก(# ก33(N7ก
2"Q'ก <@ก(# 2L
(ก <@"
2"ก<
2A<76<
ก
"<474!ก "ก73( &|กI"("#
ก ก..%. 3(
2QN6Qก%!
"<474ก
<3(&'ก
6<@%2I "
7
77 2L
(ก3("2!
"<474""&"#6
> 3 ก 2557 I(6'
('
!n'@
2@(42!ก(# กก
,' ,ก' Jก '"#"o '+ *%-+ &.
© Copyright 2025